Raymond James Financial
CLBT icon

Raymond James Financial’s Cellebrite CLBT Stock Holding History

Raymond James Financial’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.4M Sell
1,389,889
-63,207
-4% -$953K 0.01% 1535
2025
Q4 		$26.1M Sell
1,453,096
-42,789
-3% -$768K 0.01% 1257
2025
Q3 		$27.7M Buy
1,495,885
+80,539
+6% +$1.27M 0.01% 1190
2025
Q2 		$22.6M Buy
1,415,346
+501,625
+55% +$8.94M 0.01% 1265
2025
Q1 		$17.8M Buy
913,721
+460,021
+101% +$9.68M 0.01% 1396
2024
Q4 		$10M Buy
+453,700
New +$8.73M ﹤0.01% 1843

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Raymond James Financial's CLBT Position: Q1 2026 in Review

Raymond James Financial reduced its Cellebrite (CLBT) stake by 4.3% in Q1 2026, selling an estimated $953K and leaving 1,389,889 shares worth $18.4M. The position accounts for 0.01% of the portfolio, ranked #1535.

Raymond James Financial first reported a position in CLBT in Q4 2024 and has held it in 6 quarters since. The position peaked at $27.7M in Q3 2025. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Raymond James Financial held 1,389,889 shares of Cellebrite worth $18.4M as of Q1 2026.
  • Raymond James Financial sold 63,207 Cellebrite shares in Q1 2026, an estimated $953K.
  • Cellebrite made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #1535 holding.
  • Raymond James Financial first reported a position in Cellebrite in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Cellebrite position peaked at $27.7M in Q3 2025.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.